Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways

Abstract Background Osteoarthritis (OA) is considered an advancing chronic degenerative joint disease, leading to severe physical functional impairment of patients. Its development is closely related to increased inflammation and oxidative stress within the joint. Ginkgetin (GK), a natural non-toxic...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang Zhu, Yanchi Bi, Ting Liang, Po Zhang, Xiao Xiao, Tengbo Yu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-025-05525-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861837916012544
author Liang Zhu
Yanchi Bi
Ting Liang
Po Zhang
Xiao Xiao
Tengbo Yu
author_facet Liang Zhu
Yanchi Bi
Ting Liang
Po Zhang
Xiao Xiao
Tengbo Yu
author_sort Liang Zhu
collection DOAJ
description Abstract Background Osteoarthritis (OA) is considered an advancing chronic degenerative joint disease, leading to severe physical functional impairment of patients. Its development is closely related to increased inflammation and oxidative stress within the joint. Ginkgetin (GK), a natural non-toxic chemical, has proven anti-inflammatory, antioxidant, anti-tumor, and neuroprotective effects. Methods First, this study utilizes network pharmacology to explore the intrinsic connection between GK and OA. In vitro, SW1353 human cartilage cells were stimulated with Tert-butyl hydrogen peroxide (TBHP), and different GK concentrations were pre-treated to evaluate its protective effects. GK's anti-inflammatory and antioxidative effects were comprehensively assessed via MTT assay, western blot, cell immunofluorescence, ELISA, and transcriptome sequencing. Potential underlying mechanisms were also explored. In vivo, OA was induced in rats via anterior cruciate ligament transection (ACLT), and GK's impact on cartilage protection was further assessed via histological analysis and western blot. Results Network pharmacology has revealed that GK regulates OA via several key pathways, especially NF-κB, HIF-1, PI3K-AKT, and substances like reactive oxygen species. In vitro experiments showed GK effectively reverses oxidative stress damage from TBHP, inhibits inflammatory factor release, and protects Extracellular matrix (ECM) from degradation. These functions may be achieved via the NF-κB and MAPK signaling pathways. In vivo experiments showed GK significantly reduced proteoglycan loss from ACLT and inhibited matrix metalloproteinase 13 (MMP13) and ADAMTS5 (A disintegrin and metalloproteinase with thrombospondin motifs 5) production, effectively preventing cartilage degeneration in rats. Conclusion These findings suggest that GK has potential as a therapeutic agent for OA, offering new strategies and directions for OA treatment.
format Article
id doaj-art-b72189cbc4f94eae9450610fed9e44ca
institution Kabale University
issn 1749-799X
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj-art-b72189cbc4f94eae9450610fed9e44ca2025-02-09T12:46:59ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2025-02-0120112010.1186/s13018-025-05525-5Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathwaysLiang Zhu0Yanchi Bi1Ting Liang2Po Zhang3Xiao Xiao4Tengbo Yu5Department of Orthopedic Surgery, Qingdao Municipal Hospital, Qingdao UniversityDepartment of Orthopedic Surgery, Qingdao Municipal Hospital, Qingdao UniversityRehabilitation Section, Qingdao Municipal Hospital, Qingdao UniversityDepartment of Orthopedic Surgery, Qingdao Municipal Hospital, Qingdao UniversityCentral Laboratories, Qingdao Municipal Hospital, University of Health and Rehabilitation SciencesDepartment of Orthopedic Surgery, Qingdao Municipal Hospital, University of Health and Rehabilitation SciencesAbstract Background Osteoarthritis (OA) is considered an advancing chronic degenerative joint disease, leading to severe physical functional impairment of patients. Its development is closely related to increased inflammation and oxidative stress within the joint. Ginkgetin (GK), a natural non-toxic chemical, has proven anti-inflammatory, antioxidant, anti-tumor, and neuroprotective effects. Methods First, this study utilizes network pharmacology to explore the intrinsic connection between GK and OA. In vitro, SW1353 human cartilage cells were stimulated with Tert-butyl hydrogen peroxide (TBHP), and different GK concentrations were pre-treated to evaluate its protective effects. GK's anti-inflammatory and antioxidative effects were comprehensively assessed via MTT assay, western blot, cell immunofluorescence, ELISA, and transcriptome sequencing. Potential underlying mechanisms were also explored. In vivo, OA was induced in rats via anterior cruciate ligament transection (ACLT), and GK's impact on cartilage protection was further assessed via histological analysis and western blot. Results Network pharmacology has revealed that GK regulates OA via several key pathways, especially NF-κB, HIF-1, PI3K-AKT, and substances like reactive oxygen species. In vitro experiments showed GK effectively reverses oxidative stress damage from TBHP, inhibits inflammatory factor release, and protects Extracellular matrix (ECM) from degradation. These functions may be achieved via the NF-κB and MAPK signaling pathways. In vivo experiments showed GK significantly reduced proteoglycan loss from ACLT and inhibited matrix metalloproteinase 13 (MMP13) and ADAMTS5 (A disintegrin and metalloproteinase with thrombospondin motifs 5) production, effectively preventing cartilage degeneration in rats. Conclusion These findings suggest that GK has potential as a therapeutic agent for OA, offering new strategies and directions for OA treatment.https://doi.org/10.1186/s13018-025-05525-5GinkgetinOsteoarthritisNetwork pharmacologyOxidative stress
spellingShingle Liang Zhu
Yanchi Bi
Ting Liang
Po Zhang
Xiao Xiao
Tengbo Yu
Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
Journal of Orthopaedic Surgery and Research
Ginkgetin
Osteoarthritis
Network pharmacology
Oxidative stress
title Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
title_full Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
title_fullStr Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
title_full_unstemmed Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
title_short Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
title_sort ginkgetin delays the progression of osteoarthritis by inhibiting the nf κb and mapk signaling pathways
topic Ginkgetin
Osteoarthritis
Network pharmacology
Oxidative stress
url https://doi.org/10.1186/s13018-025-05525-5
work_keys_str_mv AT liangzhu ginkgetindelaystheprogressionofosteoarthritisbyinhibitingthenfkbandmapksignalingpathways
AT yanchibi ginkgetindelaystheprogressionofosteoarthritisbyinhibitingthenfkbandmapksignalingpathways
AT tingliang ginkgetindelaystheprogressionofosteoarthritisbyinhibitingthenfkbandmapksignalingpathways
AT pozhang ginkgetindelaystheprogressionofosteoarthritisbyinhibitingthenfkbandmapksignalingpathways
AT xiaoxiao ginkgetindelaystheprogressionofosteoarthritisbyinhibitingthenfkbandmapksignalingpathways
AT tengboyu ginkgetindelaystheprogressionofosteoarthritisbyinhibitingthenfkbandmapksignalingpathways